Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting

26 May 2021

Abstract excerpt

Importance: Pharmacogenomic (PGx) testing provides preemptive pharmacotherapeutic guidance regarding the lack of therapeutic benefit or adverse drug reactions of PGx targeted drugs. Pharmacogenomic information is of particular value among children with complex medical conditions who receive multiple medications and are at higher risk of developing adverse drug reactions. Objectives: To assess the implementation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics and Rare Diseases
Share to Pharmaceutical studies and practices
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34037732
DOI: 10.1001/jamanetworkopen.2021.10446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care SettingPMID 34037732Read ↗

Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.Semantic proximity Read ↗

Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing Panel.Semantic proximity Read ↗

Retrospective Review of Pharmacogenetic Testing at an Academic Children’s HospitalSemantic proximity Read ↗

Implementation of pharmacogenomics: Where are we now?Semantic proximity Read ↗

Critically Ill Children Frequently Receive Medications with Established but Unused Pharmacogenomic Guidelines: Actionable Findings from an Integrated Electronic Medical Record and Exome Sequencing StudySemantic proximity Read ↗

Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?Semantic proximity Read ↗

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.Semantic proximity Read ↗

Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyondSemantic proximity Read ↗

Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort studySemantic proximity Read ↗

Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.Semantic proximity Read ↗

Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing MedicineSemantic proximity Read ↗

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.